FDA.reportPublic FDA data

sebetralstat 300 MG Oral Tablet [Ekterly]

RxCUI
2717955
RxNorm name
sebetralstat 300 MG Oral Tablet [Ekterly]
Display name
sebetralstat 300 MG Oral Tablet [Ekterly]
Full name
sebetralstat 300 MG Oral Tablet [Ekterly]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EKTERLYSEBETRALSTATKalVista Pharmaceuticals Ltd1d145e2f-8e7e-2e90-e063-6294a90a44492026-04-01Adverse reactionsExact identifier
rxcui: 2717955

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1d145e2f-8e7e-2e90-e063-6294a90a4449Ekterly 300 MG Oral Tablet [PSN] · sebetralstat 300 MG Oral Tablet [Ekterly] [SBD] · Ekterly 300 MG Oral Tablet [SY]34These highlights do not include all the information needed to use EKTERLY safely and effectively. See full prescribing information for EKTERLY. EKTERLY (sebetralstat) tablets, for oral use Initial U.S. Approval: 202520260401